Cargando…
MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
BACKGROUND: Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors characterized by their aggressive nature and poor associated survival. MicroRNAs (miRs) have been found to play an important role in the occurrence and development of human cancers, but their role in the prognosis of...
Autores principales: | Lü, Lingshuang, Mao, Xuhua, Shi, Peiyi, He, Biyu, Xu, Kun, Zhang, Simin, Wang, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459744/ https://www.ncbi.nlm.nih.gov/pubmed/28562579 http://dx.doi.org/10.1097/MD.0000000000007085 |
Ejemplares similares
-
Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020) -
Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021) -
MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis
por: Xiao, Dachun, et al.
Publicado: (2021) -
Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020) -
Association Between Histone Methyltransferase hSETD1A and Prognosis in Patients With Triple-Negative Breast Cancer After Surgery: A Retrospective Study in the Chinese Female Population
por: Zhu, YanYan, et al.
Publicado: (2016)